What is the appropriate discharge regimen for a patient receiving a high daily dose of intravenous insulin, transitioning to pre‑meal rapid‑acting insulin boluses, basal insulin glargine, and oral hypoglycemic agents?

Transitioning from IV to Subcutaneous Insulin at Hospital Discharge

For a patient on high-dose IV insulin transitioning to discharge, calculate the total daily subcutaneous insulin dose as 50% of the 24-hour IV insulin requirement, split equally between basal glargine (given once daily in the evening) and rapid-acting prandial insulin (divided across three meals), while resuming oral hypoglycemic agents based on renal function and prior glycemic control. 1

Calculating the Transition Dose

The most widely validated approach uses the Avanzini model for IV-to-subcutaneous conversion 1:

• Calculate total 24-hour IV insulin dose from the stable period (last 12-24 hours when glucose was controlled at 1.8-10 mmol/L or 100-180 mg/dL) 1
• Give 50% as basal glargine administered once daily in the evening 1
• Give 50% as rapid-acting insulin divided equally before three meals (breakfast, lunch, dinner) 1
• Administer basal insulin immediately when stopping IV insulin to prevent rebound hyperglycemia 1

Example calculation: If the patient required 72 units of IV insulin over 24 hours:

• Basal glargine: 36 units once daily (evening)
• Rapid-acting insulin: 12 units before each meal 1

Alternative Conservative Approach

Some guidelines recommend an 80% conversion for patients with high insulin requirements (>0.6 units/kg/day at home), where 80% of the IV dose becomes basal insulin with additional rapid-acting coverage 1. However, the 50/50 split remains the most commonly used and validated approach 1.

Timing Considerations

Critical timing requirements to prevent hyperglycemic rebound 1:

• Stop IV insulin only when glucose is stable (<10 mmol/L or 180 mg/dL) for at least 24 hours 1
• Give basal glargine 2-4 hours before discontinuing IV insulin 1
• Optimal timing for first basal dose is 20:00 hours (8 PM) 1
• If transitioning before 20:00, adjust the dose proportionally and give the full dose at 20:00 1
• Do not stop IV insulin if infusion rate is >5 units/hour, as this indicates severe insulin resistance 1

Oral Hypoglycemic Agent (OHA) Management

Resume OHAs based on admission HbA1c and renal function 1, 2:

If HbA1c <8% 1:

• Resume previous OHA regimen at same doses after 48 hours
• Requires eGFR >30 mL/min for most OHAs, >60 mL/min for metformin 1
• Gradually taper rapid-acting insulin as OHAs take effect
• Follow-up with primary physician within 1-2 weeks 1

If HbA1c 8-9% 1:

• Continue basal-bolus insulin regimen
• Add or optimize OHAs (metformin if eGFR ≥45 mL/min) 1
• Arrange endocrinology consultation 1

If HbA1c >9% 1:

• Maintain full basal-bolus regimen
• Request endocrinology consultation before discharge
• Consider hospitalization in specialized diabetes service 1

Dose Adjustments for Safety

Reduce initial doses in high-risk patients 1:

• Elderly patients (>65 years): Start with 0.15-0.25 units/kg/day total 1
• Renal insufficiency: Reduce by 20-30% due to decreased insulin clearance 1
• Poor oral intake: Give only 50% of planned prandial doses 1
• Patients on high home insulin (≥0.6 units/kg/day): Reduce total daily dose by 20% to prevent hypoglycemia 1

Prandial Insulin Management

Adjust rapid-acting insulin based on nutritional intake 1:

• Full prandial dose only if adequate caloric intake expected
• Half dose if light meal or uncertain intake 1
• Hold prandial insulin if patient is NPO (nothing by mouth) 1
• Use correction doses (supplemental insulin) for pre-meal glucose >250 mg/dL (13.9 mmol/L): add 2-4 units 1

Common Pitfalls to Avoid

Critical errors that increase morbidity 1:

1. Never use sliding-scale insulin alone without basal insulin—this is associated with poor glycemic control and increased complications 1
2. Do not stop IV insulin before giving subcutaneous basal insulin—causes rebound hyperglycemia and potential ketoacidosis 1
3. Avoid premixed insulins (70/30,75/25)—associated with unacceptably high hypoglycemia rates in hospital settings 1
4. Do not give rapid-acting insulin at bedtime—increases nocturnal hypoglycemia risk 1
5. Never transition if IV insulin rate >5 units/hour—indicates inadequate control requiring continued IV therapy 1

Monitoring and Follow-up

Post-transition glucose monitoring requirements 1:

• Check blood glucose every 2-4 hours initially, then before meals and bedtime 1
• Target range: 100-180 mg/dL (5.6-10.0 mmol/L) 1
• Document all hypoglycemia (<70 mg/dL) and adjust regimen if occurs 1
• If >50% of readings above target over 2 weeks, increase insulin by 2 units 1
• If >2 readings/week <80 mg/dL, decrease insulin by 2 units 1

Discharge planning 3, 2:

• Provide written insulin administration instructions
• Arrange diabetes education before discharge
• Schedule follow-up within 1-4 weeks based on HbA1c 1
• Ensure patient/caregiver can demonstrate proper injection technique 3